AZA Combined with R-GemOx for Elderly DLBCL Patients
Status:
NOT_YET_RECRUITING
Trial end date:
2028-01-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single-arm, multicenter, phase II clinical trial to evaluate the efficacy and safety of AZAazacytidinecombined with the R-GemOx (rituximab, gemcitabine and oxaliplatin) regimen as first-line treatment in elderly diffuse large B-cell lymphoma (DLBCL) patients.
Phase:
PHASE2
Details
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University